EUVIMEDEUVIMED entdecken
Crossref

Thrombotic Complications of Low‐Dose Versus High‐Dose Four‐Factor Prothrombin Complex Concentrate for Massive Bleeding in Pediatric Cardiovascular Surgery

Laura Palacio-Guzmán, Sergio Alzate-Ricaurte iD, Natalia Plata-Ayala, Andres Pombo-Jiménez, Gustavo Adolfo Cruz-Suarez iD

Pediatric Anesthesia · 2025-08 · 35 (8) · 619-626

DOI: 10.1111/pan.15118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Anesthesia, online erschienen am 28.05.2025. Verfasst von Laura Palacio-Guzmán und 4 weiteren Autor:innen. Beteiligte Einrichtung: Anesthesiology Department, Fundación Valle del Lili, Cali, Colombia. Hauptthemen laut MEDLINE: Thrombosis, Blood Coagulation Factors, Cardiovascular Surgical Procedures, Postoperative Hemorrhage. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Major bleeding is a life‐threatening complication in pediatric cardiovascular surgery, particularly in neonates and infants with immature coagulation systems and congenital heart defects ( CHD ). Cardiopulmonary bypass ( CPB ) exacerbates these risks by depleting coagulation factors and platelets. Four‐factor prothrombin complex concentrates ( 4F ‐ PCC ) provide targeted hemostatic correction but carry potential thrombotic risks.

Methods

Among 1296 pediatric patients who underwent cardiovascular surgery between January 2018 and April 2024, a retrospective cohort study analyzed 104 patients who received 4F ‐ PCC . Patients were grouped into low‐dose (< 35 U/kg) and high‐dose (≥ 35 U/kg). Thrombotic complications were evaluated within 15 days after use.

Results

The median age was 1 month ( IQR : 0–7.5), and 69.23% of patients were male. Common diagnoses included hypoplastic left heart syndrome (14.42%), ventricular septal defect (13.46%), and coarctation of the aorta (12.5%). Frequent procedures included Norwood procedure (14.42%) and ventricular septal defect closure (13.46%). Thrombotic complications occurred in 6.73% overall, with no significant differences between high‐dose (5.26%) and low‐dose (8.51%) groups ( p = 0.698). High‐dose 4F ‐ PCC was associated with shorter CPB times ( p = 0.007) (Cohen's d 0.537) but higher reintervention rates (57.89% vs. 34.04%; p = 0.015) (Cramér's V 0.118).

Conclusion

High‐dose 4F ‐ PCC was not associated with increased thrombotic complications. Thrombotic complications in this study were inferior to all‐cause thrombotic complications in pediatric cardiovascular surgery of 11%. These findings support 4F ‐ PCC as a viable option for managing severe bleeding in pediatric cardiovascular surgery. Further studies should explore dose optimization and preventive applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombosisBlood Coagulation FactorsCardiovascular Surgical ProceduresPostoperative HemorrhageHumansMaleFemaleInfantRetrospective StudiesInfant, NewbornChild, PreschoolChildCohort StudiesHeart Defects, CongenitalDose-Response Relationship, Drug

Stichwörter der Autor:innen

cardiovascular surgical procedurespediatric anesthesiaprothrombin complex concentratessurgical blood lossthrombosis

Substanzen

prothrombin complex concentratesBlood Coagulation Factors

Autor:innen und Institutionen

  • Anesthesiology Department, Fundación Valle del Lili, Cali, Colombia.
  • Universidad Icesi, Facultad de Medicina, Cali, Colombia.
  • Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia.

ORCID-Profile: Sergio Alzate-Ricaurte, Gustavo Adolfo Cruz-Suarez

Zitieren

APA

Palacio-Guzmán, L., Alzate-Ricaurte, S., Plata-Ayala, N., Pombo-Jiménez, A., & Cruz-Suarez, G. A. (2025). Thrombotic Complications of Low‐Dose Versus High‐Dose Four‐Factor Prothrombin Complex Concentrate for Massive Bleeding in Pediatric Cardiovascular Surgery. Pediatric Anesthesia, 35(8), 619-626. https://doi.org/10.1111/pan.15118

Vancouver

Palacio-Guzmán L, Alzate-Ricaurte S, Plata-Ayala N, Pombo-Jiménez A, Cruz-Suarez GA. Thrombotic Complications of Low‐Dose Versus High‐Dose Four‐Factor Prothrombin Complex Concentrate for Massive Bleeding in Pediatric Cardiovascular Surgery. Pediatric Anesthesia. 2025;35(8):619-626. doi:10.1111/pan.15118

BibTeX
@article{PalacioGuzmn2025,
  author = {Palacio-Guzmán, Laura and Alzate-Ricaurte, Sergio and Plata-Ayala, Natalia and Pombo-Jiménez, Andres and Cruz-Suarez, Gustavo Adolfo},
  title = {Thrombotic Complications of Low‐Dose Versus High‐Dose Four‐Factor Prothrombin Complex Concentrate for Massive Bleeding in Pediatric Cardiovascular Surgery},
  journal = {Pediatric Anesthesia},
  year = {2025},
  volume = {35},
  number = {8},
  pages = {619--626},
  doi = {10.1111/pan.15118}
}
Kostenlos starten →